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a  b  s  t  r  a  c  t
We  have  examined  the  imprecision  in the  estimation  of  PCR  efﬁciency  by  means  of  standard  curves  based
on  strategic  experimental  design  with large  number  of  technical  replicates.  In particular,  how  robust  this
estimation  is  in  terms  of a commonly  varying  factors:  the instrument  used,  the  number  of  technical
replicates  performed  and  the  effect  of  the  volume  transferred  throughout  the  dilution  series.  We  used  six
different  qPCR  instruments,  we  performed  1–16  qPCR  replicates  per  concentration  and  we  tested  2–10  l
volume  of analyte  transferred,  respectively.  We  ﬁnd  that  the  estimated  PCR  efﬁciency  varies  signiﬁcantly
across  different  instruments.  Using  a Monte  Carlo  approach,  we ﬁnd  the  uncertainty  in  the PCR  efﬁciency
estimation  may  be  as  large  as  42.5%  (95%  CI)  if standard  curve  with  only  one  qPCR  replicate  is  used inmpliﬁcation efﬁciency
tandard curve
ilution series
PCR assay validation
16  different  plates.  Based  on  our  investigation  we  propose  recommendations  for the  precise estimation
of  PCR  efﬁciency:  (1) one  robust  standard  curve  with  at least  3–4 qPCR  replicates  at each concentration
shall  be generated,  (2)  the  efﬁciency  is instrument  dependent,  but reproducibly  stable  on  one  platform,
and  (3)  using  a  larger  volume  when  constructing  serial dilution  series  reduces  sampling  error  and  enables
calibration  across  a wider  dynamic  range.
©  2015  The  Authors.  Published  by Elsevier  GmbH.  This  is an  open  access  article  under  the  CC  BY. Introduction
Literature search (e.g. Pubmed) for scientiﬁc publications using
he keyword “quantitative PCR” (qPCR) retrieves hundreds of thou-
ands of hits, manifesting that qPCR has become mainstream life
ciences technology [1–3]. It is widely acknowledged as the most
ensitive method to quantify minute amounts of nucleic acids and
ts applications split into two main types referred to as: relative
4,5] and absolute [6–8] quantiﬁcation. In relative quantiﬁcation
Abbreviations: RT-qPCR, reverse transcription-quantitative polymerase chain
eaction; ANCOVA, analysis of covariance; E, PCR efﬁciency; Cq, cycle of quantiﬁ-
ation; GMO, genetically modiﬁed organism; ISO, International Organization for
tandardization; IEC, International Electrotechnical Commission; RIN, RNA Integrity
umber; NTC, no template control; FDA, food and Drug Administration; EPA, Envi-
onmental protection agency; CLSI, Clinical and Laboratory Standards Institute;
IQE, minimum information for publication of quantitative real-time PCR experi-
ents.
∗ Corresponding author at: Institute of Biotechnology, Academy of Science of the
zech Republic, Prague, Czech Republic.
E-mail address: david.svec@ibt.cas.cz (D. Svec).
ttp://dx.doi.org/10.1016/j.bdq.2015.01.005
214-7535/© 2015 The Authors. Published by Elsevier GmbH. This is an open access articlicense  (http://creativecommons.org/licenses/by/4.0/).
the analyte, often reverse-transcribed mRNA or microRNA, is
quantiﬁed relative to an endogenous reference [4,5]. In absolute
quantiﬁcation the targeted nucleic acid (the analyte) is measured
relative to a set of standards used to construct a standard curve
[6–8]. The established name “absolute quantiﬁcation”, is rather
confusing, since absolute value are never determined; a more
appropriate name would be “calibration”, as the concentration of
the ﬁeld sample in fact is measured “relative” to the concentrations
of the standard samples.
The standard curve is also used to assess the performance of
qPCR assay by estimating its efﬁciency [9] and optionally also
determining the assay dynamic range, limit of detection and
limit of quantiﬁcation. For the estimation of PCR efﬁciency the
standard used to construct the standard curve does not have to
be calibrated. The efﬁciency (E) of PCR is deﬁned as the fraction
of target molecules that are copied in one PCR cycle [10,11]. A
properly designed assay shall, in the absence of interfering sub-
stances in the sample matrix, amplify target DNA with at least 90%
efﬁciency [12,13]. However, the experimental determination of
PCR efﬁciency has been subject of many discussions, resulting even
in some very inappropriate recommendations, such as to perform
le under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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eparate standard curves with few data points in every qPCR run
o account for inter run variation. There is also a qPCR community
hat focuses on alternative procedures estimate PCR efﬁciency
ased on the analysis of individual ampliﬁcation curves [14,15]. In
pite of these heroic efforts, the standard curve remains the most
eliable and robust approach to estimate PCR assay efﬁciency that
s broadly accepted by the community [16], while some of the
lternative approaches have found use as quality control tools in
igh-throughput setups [17–19].
The estimation of PCR efﬁciency by means of a standard curve
nvolves generating a series of samples with controlled relative
mounts of targeted template. These samples are usually con-
tructed by serial dilution of a concentrated stock solution, most
requently using 10-fold dilution steps. The so prepared standard
amples are analyzed by qPCR measuring the quantiﬁcation cycle
Cq) using standard procedures. A plot of the Cq’s versus the log-
rithm of the target concentrations is constructed and is expected
o be linear with a negative slope. For a 10-fold dilution series the
lope is −3.33 when E = 100%. This follows from the assumption of a
erfect doubling of the number of DNA template molecules in each
tep of the PCR (Eq. (1)).
x = N02x (1)
Where Nx is the number of target molecules after x cycles and
0 is the initial number of double stranded target molecules. If the
nitial template is single stranded, such as cDNA, the ﬁrst PCR cycle
roduces its complement rather than doubling it (Eq. (2)).
x = N02(x−1) (2)
In practice, perfect doubling of the number of molecules in every
ycle is highly uncommon; rather a fraction only is copied, which is
he PCR efﬁciency (E). Hence, E is a number expected to be between
 and 1 and is frequently expressed as percentage (Eq. (3)).
x = N0(1 + E)(x−1) (3)
For example, let say a test tube contains 100 target molecules
nd after one ampliﬁcation cycle it contains 180 molecules, E = 80%,
ince 80% of the target molecules present were ampliﬁed. In prac-
ice we do not measure the number of amplicons; rather we
easure the ﬂuorescence (I) from dyes or probes present in the
eaction mix  that bind to the amplicons formed (Eq. (4)).
 = k′(assay 1) × Nx (4)
The ﬂuorescence (I) depends on the amount of amplicon formed
Nx) and k′ is a proportionality constant. It reﬂects the amount of ﬂu-
rescence produced per amplicon formed, and may  change during
he course of the reaction as the reporter/DNA ratio changes. The
hermodynamics behind is complex, although some brave attempts
o model it have been made [20]. Modelling the thermodynamics
s, however, not needed in order to compare samples at a ﬂuores-
ence threshold (Ithreshold), which is the normal practice to analyze
PCR data, since at threshold all reactions based on the same assay
ontain the same number of amplicons (Eq. (5)):
threshold = k′ × N0(1 + E)(Cq−1) (5)
nd the effect of k′ cancels. Rearranging Eq. (5) produces the relation
etween PCR efﬁciency and the slope of the standard curve found
n textbooks (Eq. (6)) [2,21].
 = 10−(1/slope) − 1 (6)
The PCR efﬁciency depends on many factors including: (1) thessay performance, which depends on the primers’ and template
equences and structures. Secondary structure and opportunity
or undesired intra-molecular interactions reduce PCR efﬁciency;
2) the sample matrix, which may  contain inhibitors and othernd Quantiﬁcation 3 (2015) 9–16
interfering substances from the sample or carry overs agents from
upstream processing steps; (3) reagents used and their concen-
trations. Essentially, any of the PCR reagents can be rate and
performance limiting [22] including PCR protocol; and (4) com-
peting reactions.
The samples shall be tested for inhibition, which is easy done
using RNA or DNA spikes [23,24]. It can also be observed by per-
forming a serial dilution [25]. In fact inhibition is often the cause of
unrealistic PCR efﬁciency estimates (E > 100%) as it is pronounced in
the most concentrated samples leading to deviation from linearity.
If ignored and mistakenly included in the linear ﬁt, those samples
reduce the slope leading to too high PCR efﬁciency estimates. In
some cases inhibition is pronounced only in the upstream reactions
such as the reverse transcription and not noticed in qPCR.
A template must be chosen for the assessment as well as the
matrix. Choosing a matrix characteristic of the ﬁeld sample the
estimated efﬁciency will reﬂect the performance of the PCR assay
in the actual samples that will be analyzed. This, however, requires
pure matrix is available. Usually a new assay is ﬁrst validated in a
pure matrix devoid of interfering agents. Assays that show high PCR
efﬁciency are robust and will be less prone to inhibition in complex
matrices. Puriﬁed PCR product is often used as template for PCR efﬁ-
ciency estimates, because it is easy to produce. However, it often
leads to side reactions because of its short length, and it does not
reﬂect the effect of ﬂanking sequences that may  interfere with PCR
by wrapping onto the template [26]. Such interference can be sig-
niﬁcant in the initial cycles of the PCR, when the original template is
abundant, and inﬂuence the measured Cq. For validation of assays
for gene expression proﬁling a cDNA library is a suitable source of
long template molecules with representative secondary structures.
Genomic DNA or plasmids containing the gene of interest can be
used as standard for validation of assays for DNA  analysis, prefer-
ably after excising a fragment containing the target sequence to
remove interfering supercoiling [26]. Still another option is to use
synthetic templates (e.g. gBlocks – IDT, GeneArt – LT).
The performance of new assays needs to be tested by means
of speciﬁcity, efﬁciency and sensitivity (sometimes also for limits
of detection and quantiﬁcation). While properties of a good qPCR
assay are well described by means of speciﬁcity in MIQE guidelines
[16], where tests and optimal criteria are recommended, e.g. in sil-
ico BLAST (single unique complementarity), electrophoresis (single
band of correct size), melt curve (single peak in target ampliﬁca-
tion, no peaks in NTC while Cq of NTC ≤40 can be ignored if Cq
of NTC and target is ≤5), “no RT” control (Cq of no RT and RT
≤5). Detailed piece of information about what parameters to use
for optimal efﬁciency estimate using standard curves was  miss-
ing and our work offers detailed evidence. The PCR efﬁciency is
one of the most important indicator of the performance of a qPCR
assay and is also required parameter for quantitative analysis when
fold changes are calculated. Proper usage of PCR efﬁciency in qPCR
analysis requires it is estimated with high precision. Inaccurate esti-
mations of Ex can lead to substantial under- or overestimation of
the calculated fold change, particularly when large differences in
expression are measured (Fig. 1).
The aim of this study is to test the impact of three experimen-
tal factors on the precision of the estimated PCR efﬁciency: (1)
the effect if qPCR instrument changes; (2) the effect of how many
technical replicates are included; and (3) the effect of the volume
transferred across dilutions.
2. ResultsWe  tested three experimental factors in terms of precision of the
estimated PCR efﬁciency: (1) the effect of the qPCR instrument; (2)
the impact of the number of technical replicates; and (3) the effect
D. Svec et al. / Biomolecular Detection and Quantiﬁcation 3 (2015) 9–16 11
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Fig. 2. PCR efﬁciency estimated for three selected assays using six different instru-ig. 1. Impact of PCR efﬁciency on fold change between two conditions. Model
hows how determination of efﬁciency impacts relative fold change calculated in
erms of difference in Cq values (Cq).
f the volume transferred across dilutions. In all cases we postulate
he null hypothesis as there is no difference to be observed due to
hese three factors.
.1. The effect of the qPCR instrument
We  performed one dilution series consisting of 10-fold dilu-
ion of 6 concentrations, each was analyzed using 4 qPCR replicates
6 × 4) on 6 different qPCR instruments: Eppendorf RealPlex, Bio-
ad CFX96, AB StepOne, AB 7500Fast, Corbett Rotorgene I, Roche
C480. Three highly abundant rRNA (18S) and mRNAs (Hprt, H2afz)
ere used to minimize the effect of sampling error.
The slopes of the standard curves were compared with Analysis
f covariance (ANCOVA) using a model based on the three terms (i),
ii) and (iii) which were tested simultaneously using the SS II type of
rror. Sum of squares were calculated and the p-values associated
ith the F-distribution were obtained.
(i) The impact of instrument on the standard curve intercept
was very signiﬁcant (p < 0.0001). This was expected, since the
Cq-values and, hence, the intercept depends on instrument
settings (gain, threshold) as well as instrument factors, such
as excitation and emission details (wavelengths, slit widths,
ﬁlters, exposure time, etc.).
(ii) The effect of log10(dilution) with p < 0.0001 is what describes
the slope of the curve and the expected growing Cq value in
response to decreasing concentration, in other words the qPCR
efﬁciency.
iii) The interaction between the instrument and the slope is the
relevant test result. It reﬂects correlation of the instrument
used and the slope of the standard curve, which in turn deter-
mines the PCR efﬁciency. Hence, this reﬂects the inﬂuence
of the qPCR instrument on the measured PCR efﬁciency. Test
result was very signiﬁcant (p < 0.0001).
Our results show that the qPCR instrument used has an impact
n the efﬁciency estimate (Fig. 2). Hence, the same assay in the same
atrix experiences different PCR efﬁciency in different instru-
ents. Most likely this is due to instrument speciﬁc hardware
roperties and settings, software settings and the particular algo-
ithm used to extract the Cq values.
The objective of this study was not to compare instruments in
rder to ﬁnd a best one, since performance may  depend on the reac-
ion conditions chosen, but to test if there is an effect of instrument.
esults are clear; there is signiﬁcant effect. The instrument speciﬁc
roperties conceived to affect the PCR efﬁciency are the reaction
ontainer, which here in most cases were plastic microtiter wellments. Error bars indicate 95% conﬁdence interval. Efﬁciencies were estimated from
standard curves based on ten-fold dilutions based on six concentrations, each ana-
lyzed in four qPCR replicates.
plates, that inﬂuences the rate and efﬁciency of heat transfer, the
heating and cooling capacities, which may  induce thermal over-
and undershoots, the thermal unit and its control of the actual
temperatures in the reaction mix  (instruments generally register
the temperature of the heating block, which may differ from the
temperature of the reaction mix), and the heating and cooling rates.
2.2. The effect of technical replicates
We collected two data sets to test the impact of technical repli-
cates on the precision of the estimated PCR efﬁciency. In the ﬁrst
data set we  used 6 dilution steps that each was  measured in 4
qPCR replicates for 18S. To test the inﬂuence of replicates the data
were analyzed as follows. We  performed more than 1000 samplings
of the data randomly selecting one, two or three out of the four
technical replicates at each concentration, and compared these to
evaluate the robustness of the standard curve method to estimate
PCR efﬁciency. With samplings we tested the majority of all possible
combinations and accurately modelled the imprecision of the esti-
mation of E. The impression, measured as standard deviation (SD),
of E depends on the number of technical replicates at each concen-
tration (Supplement Table 1). Employing a permutation test with
3 replicates we obtained 0.934 < E < 0.966, SD = 0.007. With 2 repli-
cates 0.923 < E < 0.980, SD = 0.013, while with a single measurement
at each concentration we  obtained 0.894 < E < 0.991, SD = 0.022. The
impression, expressed as conﬁdence interval, ranges from 8.3%
without replicates to 2.3% when performing triplicates. Best esti-
mate of E is expected with all four technical replicates. This gave
12 D. Svec et al. / Biomolecular Detection and Quantiﬁcation 3 (2015) 9–16
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dig. 3. Effect of transfer volume when constructing standards by means of serial dil
nd  10 l. Each standard curve was based on ten-fold dilutions for 6 concentration
ach  dilution step for each transfer volume tested, and were subject to Monte Carlo
 = 0.951 (Supplement Table 1). SD cannot be estimated for four
eplicates by resampling, since only a single sampling is available,
ut it can be estimated from the error of the slope (Eq. (7)):
E(E) = SE(slope) × (1 + E) ln 10
slope2
(7)
This gives SE(E) = 0.008. From SE(E) the 95% conﬁdence interval
s calculated as Eq. (8).
¯ t ± t95%,n−2 × SE(E¯t) (8)
nd was 2.6% as no selection of “best” datapoints was possible,
ompared to triplicate assessment.
Supplementary Table 1 related to this article can be found, in
he online version, at doi:10.1016/j.bdq.2015.01.005.
The second data set was also based on six 6 concentrations, each
nalyzed in 16 qPCR replicates. Also with this set the accuracy of
he efﬁciency estimate increased with the number of replicates.
or the highly abundant 18S ribosomal RNA the conﬁdence interval
ecreased from 12.4% to 0.8% when increasing the number of qPCR
eplicates from one to 15 replicates. For mRNAs the uncertainty
ropped from 32.0% to 3.1% (H2afz) and 42.5% to 3.3% (Hprt) when. Four dilution series were constructed using each of the transfer volumes 2 l, 5 l
h analyzed in four qPCR replicates. This gave a total of 16 qPCR measurements at
sis. Missing data were not replaced or imputed in the analysis.
increasing from one to 15 qPCR replicates (Fig. 3). This comparison
suggest the precision of PCR efﬁciency estimate also depends on
the concentration of the target RNA, or strictly on the target cDNA
produced, due to sampling error, which becomes pronounced in the
most diluted steps [27,28]. This may  be a problem when total RNA
or cDNA library is used to produce standards by sequential dilution
for efﬁciency estimations of new assays and the concentrations of
target transcripts are unknown. We  therefore also tested the effect
of the volume transferred when constructing the standards by serial
dilution.
2.3. The impact of transfer volume in serial dilutions
To test the impact of transfer volume when constructing
standard samples by serial dilution of a concentrated stock on
the imprecision of the PCR efﬁciency estimate, we constructed
standards using transfer volumes of 10 l, 5 l and 2 l. Four inde-
pendent sets of standards were constructed by serial dilution with
each transfer volume. Each standard curve had 6 concentrations
made by 10-fold dilution and the mRNA targets were analyzed
at each concentration in 4 qPCR replicates. The diluted samples
D. Svec et al. / Biomolecular Detection a
Fig. 4. Effect of the transfer volume used in the serial dilution to construct the
standards on the number of positive ampliﬁcation reactions (hits) and on the
repeatability of technical replicates at the most diluted standard. Transfer volumes
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dere 10 l, 5 l and 2 l. Four dilution series were performed for each transfer vol-
me  and each assay, based on 6 concentrations and analyzed in qPCR tetraplicates,
esulting in 16 qPCR datapoints per concentration per assay per volume.
f all tested volumes should have therefore identical concentra-
ions. In total, for each target and transfer volume we obtained a
aximum of 16 Cq values at each concentration. We  selected 18S
RNA to represent a target with high-abundancy over the whole
ilution series, while Hprt and H2afz represent more “real life”
ranscripts, which may  reach the level of very few copies within
he dilution series. If very few copies are present per sample, rapid
ncrease of sampling error and loss of data are observed and usually
ake the efﬁciency estimate less reliable. For each target a total of
88 (3 transfer volumes × 4 standard curves × 6 concentrations × 4
eplicates) qPCR measurements were performed using 384 block
f LC480. Some of qPCRs, in the most extensively diluted standards
or the least abundant genes did not yield Cq values. The data were
nalyzed by comparing the frequency of missing data for each tar-
et at each concentration and the SD of the qPCR replicates (Fig. 4).
or the abundant 18S rRNA no dependence of transfer volume on
he precision of the PCR efﬁciency estimate was observed, pre-
umably because its concentration never reaches below the 30–35
opies per transferred volume, where sampling error due to Poisson
istribution becomes signiﬁcant [29]. For Hprt mRNA SD of qPCRnd Quantiﬁcation 3 (2015) 9–16 13
replicates and the frequency of missing at the most diluted sam-
ple increased with lower transfer volume. When using 2 l  transfer
volume 31.25% of the replicates at the most diluted standard were
missing and SD = 2.05 cycles. For 5 l transfer volume frequency
of missing data at lowest concentration was  25.0% and SD = 1.74
cycles. For 10 l transfer volume no data were missing and SD = 0.85
cycles. H2afz transcripts were even less abundant. Important sam-
pling error was introduced and the frequency of missing data in
the most diluted sample was large: frequency missing data was
68.75% and SD = 0.35 cycles with 2 l transfer volume; 50% missing
data and SD = 2.25 cycles with 5 l transfer volume; and with 10 l
transfer volume there were no missing data and SD = 1.34 cycles.
Missing data is a problem when assessing PCR efﬁciency by means
of a standard curve. Occasionally missing data are ignored by the
operator, which is wrong, since such action reduces the estimated
SD giving the imprecision data are of high quality, when, on the con-
trary, there are reproducibility issues. Rather, the dynamic range of
that particular assay is not wide enough to cover the most diluted
standard. The dynamic range is based on estimating the assay limit
of quantiﬁcation (LoQ), which is based on the SD’s of replicates and
can be done, e.g. with the GenEx software (MultiD Analysis). In our
example, we  show using larger transfer volume the precision of the
estimated PCR efﬁciency is improved and the assay dynamic range
is widened for the H2afz transcript.
3. Discussion
Validation and standardization of qPCR measurements [16,30]
and RNA processing [31] is receiving increasing attention from reg-
ulatory bodies such as the US Food and Drug Administration (FDA)
[32], the Environment Protection Agency (EPA) [33], and standard-
ization organizations such as the Clinical and Laboratory Standards
Institute (CLSI, earlier called NCCLS) [34] and most recently the
European Committee for Standardization (www.cen.eu) and the
International Organization for Standardization (www.iso.org), as
well as multinational projects (www.spidia.eu).
Assessing PCR efﬁciency by means of a standard curve is a qual-
ity benchmark for the assay as well as for the pre-analytical process,
if tested in representative sample matrix and is generally recom-
mended in the MIQE guidelines [16]. The estimated PCR efﬁciency
also enter calculation of gene expression regulatory levels [4,5].
Although the qPCR is a widely used technique, recommendations
on how to use a standard curve to estimate PCR efﬁciency are rare
and a general consensus or guidelines are lacking. It is known that
estimates of PCR efﬁciency may  be inﬂuenced by several exper-
imental factors. Although there is a widely elaborated statistical
theory [35,36] as well as recommendations by international orga-
nizations for clinical applications that include use of the calibration
curve [37], the PCR efﬁciency estimation requires special atten-
tion as basic principles differ from the common biochemical and
analytical procedures. The unconventional exponential character
of PCR (that can, however, be linearized by applying log transform)
requires a rather complex set-up and statistical analysis.
Using a Monte Carlo approach we tested how the number of
replicates used in the standard curve inﬂuences the precision of
the PCR efﬁciency estimate. We  also tested how robust the PCR
efﬁciency is, considering the random effect contributed by the qPCR
cycler. With our ﬁrst data set we  found the precision increased by
41% when using two replicates instead of a single measurement
at each concentration, and by 68% when using three replicates.
These observations were conﬁrmed using a second data set with
16 replicates at each concentration. In the second set we  also var-
ied the transfer volume in the serial dilution used to construct the
standards and experimentally demonstrated that larger transfer
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olumes reduce sampling error improving precision and widening
he dynamic range of the assay.
In a statistical test, when the tested factor – here the log10 dilu-
ion on the Cq – might show heterogeneity, analysis of covariance
rovides an adequate statistical ground to test the null hypothesis
f homogeneity by testing for interaction between the presumed
eterogeneity factor and the tested factor. This can be visualized in
 bar plot, similar to Fig. 2, where variation in height indicates inter-
ction. In our study we tested the effect of different instruments,
hich was profound. Similarly the effects of plastic ware, plate seal-
ng strategy, extraction kit, transportation, storage means, RT and
CR chemistries, experimental protocols as well as reagent batches,
ots and even suppliers for presumably equivalent products (i.e.
ligonucleotide suppliers) can be tested.
We show in our study that PCR efﬁciency can be estimated with
stablished statistical theory [35] in line with existing laboratory
uidelines [37,38]. Based on our ﬁndings and in accord with the
LSI guidelines, mainly the EP6-A guideline [37,38] for the estima-
ion of PCR efﬁciency (E) by means of a qPCR standard curve we
ecommend:
The standard curve used to establish ampliﬁcation efﬁciency may
be different from the standard curve used to estimate target quan-
tities in unknown ﬁeld samples. The standard curve to assess PCR
efﬁciency can be based on a clean matrix to assess the perfor-
mance of the PCR assay in absence of interference. The standard
curve used to estimate concentrations of ﬁeld samples must be
based on representative ﬁeld matrix to account for inhibition and
interference in the ﬁeld samples.
The concentration range used to establish ampliﬁcation efﬁciency
should cover the range of the anticipated experiment or routine
application and preferably expand beyond by at least 20%, since
predictive precision at the extreme concentrations of a standard
curve are always compromised. Too extensive standard curves
should be avoided, since measurements at extreme concentra-
tions may  deviate from linearity and give inaccurate estimate
of the ampliﬁcation efﬁciency. This is true at high as well as at
low target concentrations. Very high target concentration can
have such low Cq value that base-line subtraction becomes prob-
lematic. Indeed, deviations at high target concentration due to
base-line subtraction problems are likely cause of occasional
reports of PCR efﬁciencies far exceeding the theoretical maximum
of 100%. To avoid such errors a qPCR standard curve should be
tested for linearity according to EP-6 [37] to determine its linear
range (using e.g. GenEx – MultiD, SPSS). The analyte concentra-
tion does not have to be known to estimate the PCR efﬁciency.
It is sufﬁcient to know the relative concentrations between the
standards, which are given by the dilution factor when preparing
the standards by serial dilution.
Generally serial dilutions to produce standard curves are dis-
couraged because of carry-over of error [39]. In diagnostic
applications, when a limited concentration range is of interest,
standards can be produced by the mixing of a low and high con-
centrated stock. However, in most PCR applications assays shall
cover a wide dynamic range, which requires serial dilution of a
concentrated stock to produce the standard samples. It is then
advisable to use as large transfer volume as possible across the
dilution steps to minimize sampling and pipetting (DIN 12650,
ISO 8655-2) errors. We  recommend using at least 5 l transfer
volume and generally discourage pipetting volumes less than 2 l
using conventional pipettes.
Five dilution steps, corresponding to 6 different concentrations
if the stock is used as a standard, is minimum to identify the
assay linear range and reliably estimate E. CLSI guidelines [37]
recommended that ﬁve to seven concentrations in at least two
dilution series should be used when a linear performance withinnd Quantiﬁcation 3 (2015) 9–16
a routinely anticipated range is to be proven. Developers of new
methods who  want to establish linear range should use minimum
of seven to eleven concentrations covering the range of interest,
with each concentration represented by at least two replicate.
The concentrations should extend over the anticipated range by
at least 20%.
• If standard concentrations in log scale are evenly spread an even
number of concentrations is preferred due to the heaver effect.
• When used for calibration the standard curve should be deter-
mined for a standardized procedure based on a particular
extraction kit, RT kit, one type of instrument, a particularly
microtiter plate and sealing strategy, and particular batches of
reagents. If there is any change in protocol, a new reagent batch
is used, consumables are replaced or instrument is changed new
standard curve shall be collected.
• When used for calibration the standard samples shall be as similar
as possible to the ﬁeld samples to appropriately reﬂect the impact
of the sample matrix. When experiment with many biological
subjects is planned, pooled samples can be used to construct
the standards. If different types of samples are analyzed, for
example serum, plasma, urine separate standard curves shall be
constructed for each sample type.
• It is not recommended to perform separate estimates of E in each
experiment run and use it to correct for variation between runs,
since this may  potentially introduce large imprecision and even
systematic bias into the measurements that are larger than the
inter-run effect compromising data quality rather than improv-
ing it. It is particularly inadvisable to perform minimal standard
curves based on few concentrations only in each run. Such stan-
dard curves will report different PCR efﬁciency in each run, but
this variation is due to random effects in each run rather than
reﬂecting true systematic differences. Better is to perform a sin-
gle, highly precise estimation of the PCR efﬁciency at conditions
representative of the study that is used for all calculations, and
correct variation between runs using a robust inter-plate calibra-
tor instead measured at least in triplicate (e.g. TATAA Biocenter)
[40].
• When designing standard curves for calibration the entire test-
ing process shall be covered, including the pre-analytical process
comprising extraction, storage and puriﬁcation steps and reverse
transcription in the case of RNA analysis.
Factors that may  potentially inﬂuence the experiment and thus
the standard curve and PCR efﬁciency are the laboratory, operator,
chemistry, instruments, plastics, minor changes in protocol, etc.
When they have to be varied, for example, when used in large
laboratories, in inter-laboratory exercises or when products are
developed for use on multiple platforms at customer laboratories,
the inﬂuence of these factors shall be established by means of infer-
ential statistics. The procedure we used here to test the inﬂuence
of instrument is appropriate. Standard curves are constructed and
conﬁdence intervals of the slopes are established, which allows
testing the effect of interaction between the tested factor and the
log10 of the concentration on Cq by means of analysis of covariance.
4. Methods
We  designed a one factor test of robustness of the estimation
of PCR efﬁciency on different instruments within the qPCR core
facility of the Institute of Biotechnology, Prague. Further, we tested
the effect of replicate design on the imprecision of the estimated
E. Following routine practice, the standard material stock was pre-
pared only once and used as starting material in all experiments.
Reverse transcribed 18S rRNA and the mRNAs Hprt and H2afz were
used as representative targets. When assessing the sampling error
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n sequential dilution using different transfer volumes the same
DNA stock was used as starting material to construct independent
ilution series.
.1. Extraction of RNA and synthesis of cDNA
The cDNA was prepared from murine total RNA isolated sepa-
ately from liver, spleen, brain, and muscle that was pooled for RT.
rgans were homogenized in Trizol (Invitrogen) using Ultra-turrax
25 (IKA Labortechnik) immediately after collection and stored
t −80 ◦C. The isolation of total RNA was performed according to
anufacturer’s instructions without DNase treatment. Total RNA
issolved in RNase free water, stored in −80 ◦C at a concentration
f 2.9 g/l  (Nanodrop) with RNA Integrity Number (RIN) number
f 9.5 (Agilent Bioanalyzer) was used for reverse transcription (RT).
uperScript III RT kit (Invitrogen) was used to reverse transcribe
NA into cDNA in 50 l, containing 13.05 g of total RNA, 0.5 mM
f dNTP (Promega), 2.5 mM of oligo dT (18 bp, Eastport) and 2.5 mM
f random hexamers (Eastport) following manufacturer’s instruc-
ions. After RT all samples were diluted to 500 l with nuclease free
ater. All assay showed Cq larger than 10 between RT and RT(−)
ontrol evidencing negligible DNA background. Inhibition in the RT-
PCR workﬂow was tested using an RNA spike (TATAA Biocenter)
nd no inhibition was detected.
.2. Preparation of standard curves
A pipetting robot EP Motion EP5070 (Eppendorf) was  used to
onstruct all dilution series and to set up all qPCR plates. Each cDNA
ilution series was based on six cDNA standard samples prepared
y ﬁve steps of sequential 10-fold dilutions.
In the ﬁrst data set each cDNA standard was analyzed in four
PCR replicates generating a total of 24 (6 × 4) Cq values. The fol-
owing liquid handling protocol was used: 550 l of diluted cDNA
as dispensed in Standard 1 (St1), 450 l of nuclease-free water
ontaining carrier 50 ng/l LPA (GeneElute, Sigma Aldrich) was dis-
ensed into standards St2 to St6. After robotic mixing (3 cycles of
nﬂux/release of 50% volume) of St1, 50 l was transferred into St2.
ew pipette tip was used for mixing of St2 and the same procedure
as performed for each subsequent standards. The same prepared
tandards and mastermix premixed with primers for each assay
as used for all qPCR instruments. During dispensing (approx. 2 h)
ow temperature was maintained using pre-cooled metal blocks.
he liquid handling was performed in a dark room to avoid expo-
ure to light.
Dilution standards for the second data set were prepared simi-
arly: the transferred cDNA volumes were 2 l; 5 l and 10 l and
ere pipetted into 18 l; 45 l and 90 l of nuclease free water
ontaining carrier 50 ng/l LPA (GeneElute, Sigma Aldrich), respec-
ively. For each transfer volume, four independent dilution series
ere performed.
.3. qPCR ampliﬁcation
We  selected mouse 18S (refseq NR 003278.1), H2afz
NM 016750.3) and Hprt (NM 013556.2) for our study because
f its high abundance in various tissues making it possi-
le to cover a wide dynamic range. The following primers
ere used to amplify 80 bp of the 18S sequence: Fwd  5-
AGAAACGGCTACCACATCC-3, Rev 5-TTTTTCGTCACTACCTCCCC-3;
33 bp amplicon of H2afz: Fwd 5-ACAGCGCAGCCATCCTGGAGTA-
, Rev 5-TTCCCGATCAGCGATTTGTGGA-3; 115 bp amplicon
f Hprt: Fwd  5-GCTTGCTGGTGAAAAGGACCT-3, Rev 5-
TGAAGTACTCATTATAGTCAAGGGCA-3. qPCR reaction volumes
ere 20 l containing iQ SYBR Green Supermix (Bio-Rad) and a
nal concentration of 400 nM of each primer (Eastport). For thend Quantiﬁcation 3 (2015) 9–16 15
plating of the ﬁrst data set the EP motion 5070 (Eppendorf) robot
initially dispensed 15 l of mastermix containing primers (mul-
tidispense mode) and then added 5 l of diluted cDNA (pipette
mode). For the second data set the robot ﬁrst dispensed 18 l of
mastermix and then added 2 l of cDNA. All primers were designed
with Primer3 (http://frodo.wi.mit.edu/primer3/), where we  used
mostly default parameters, except: amplicon size range was  set
to 60–150 bp to minimize complexity of PCR, increase efﬁciency
and to facilitate use of the assay on fragmented material; Max. 3′
stability was set to minimum to reduce primer–dimer formations;
optimum Tm was  set to 60 ◦C, however optimal annealing tem-
perature was  validated using gradient qPCR (CFX 96, Bio-Rad) to
maintain high efﬁciency. Temperature proﬁle used was: 95 ◦C for
3 min  followed by 40 cycles of ampliﬁcation (95 ◦C for 20s, 58 ◦C
for 20 s and 72 ◦C for 20 s). Assays were validated using identical
qPCR protocol on duplicate non template controls (NTC), 2 RT
minus (RT−) controls and 5-step 5-fold dilution series with four
qPCR replicates per step with at least 90% efﬁciency (LightCycler
480, Roche Diagnostics, Germany). The formation of expected PCR
products was conﬁrmed by melting curve analysis and agarose
gel electrophoresis. All PCR products showed single peak melting
curve and uncompromised speciﬁcity.
4.4. Robustness test: the effect of instrument
As example of a robustness test of relevance in daily routine
in many qPCR laboratories the inﬂuence of qPCR instrument was
investigated. One serial dilution was used to generate 6 standard
samples that each was  measured in qPCR tetraplicates on 6 differ-
ent plates (using recommended plastic for each instrument) on 6
different instruments. The instruments were: Bio-Rad CFX 96 (Bio-
Rad), ABI 7500 Fast (Applied Biosystems), ABI StepOnePlus (Life
Technologies, Applied Biosystems), RotorGene 6000 duplex (Qia-
gen), Realplex4 gradient S Mastercycler (Eppendorf), and 384 well
plate platform LightCycler 480 (Roche Diagnostics). The same qPCR
master mix  stock was used in all runs. Linear regression was used
to associate the measured Cq values with the log10 of the dilution
factor (the true concentrations were not known). The stock concen-
tration was arbitrarily assigned 106× and each subsequent dilution
was 10-times less. The Cq as response variable, the dilution factor
and the instrument as the explanatory variables were used in a
linear statistical model (Eq. (9)).
Cqij =  + ıi + ˇi log ()ij + eij (9)
Where ı denotes the effect of instrument i on the intercept, the
ˇi log()ij denotes the Cqi response to the log of the dilution factor
 for each dilution j for instrument i (interaction). e is the resid-
ual error within the block of replicates of sample dilution j and
instrument i. The signiﬁcance of the interaction term ˇi log()ij was
tested using SAS v 9.1 for Windows, employing the GLM procedure
as follows:
proc glm data=>dataname<;
class instrument;
model ct=instrument logconc logconc*instrument/solution noint ss2;
run;
This annotation delivers p values on tests based on the hypoth-
esis of null effect of the instrument on the Cq intercept, the log of
concentration on the Cq, and the interaction between the instru-
ment and the log of the dilution factor on Cq.4.5. The effect of technical replicates
Using a Monte Carlo approach we  sampled over 1000 data sub-
sets randomly selecting one, two, or three replicates out of each
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et of four performed at each concentration. This set contained
he majority of the permutations possible and should adequately
odel the imprecision. The CI 95% taken as measure of the impreci-
ion of E, depended strongly on the number of technical replicates
erformed at each concentration (Supplement Table 1). From the
ermutations the expectation value of E and its 95% conﬁdence
nterval, taken as the samples with E in the range from the lower
.5 and the upper 97.5 percentiles around the expectation value
2.5% < E < 97.5%), was calculated for each sampling with 1, 2 and 3
andomly selected technical replicates at each concentration.
.6. The effect of volume transferred across the dilution series
Also the second data set with 16 replicates at each concentra-
ion was subjected to Monte Carlo analysis (Supplement Table 2)
o obtained expectation values for E (Figs. 3 and 4). The frequency
f missing data at highest dilution and SD of the Cq’s of the tech-
ical replicates were used as indicators of sampling error for the
erial dilutions with transfer volumes of 2 l, 5 l and 10 l. LC480
Roche) with 384 block was used for generating second data set.
Supplementary Table 2 related to this article can be found, in
he online version, at doi:10.1016/j.bdq.2015.01.005.
uthor contributions
A. Tichopad, D. Svec, M.  Kubista and MW.  Pfafﬂ wrote the main
anuscript, D. Svec performed the experiments, MIQE compliance
nd submission. Figures were prepared by V. Rusnakova. All authors
eviewed the manuscript.
ompeting ﬁnancial interests
The authors declare no competing ﬁnancial interests.
cknowledgements
This work was supported by a Large-scale integrat-
ng project Standardisation and improvement of generic
re-analytical tools and procedures for in vitro diagnostics
SPIDIA) within the 7th European Community Framework Pro-
ramme  HEALTH-F5-2008-222916, 7E09019 via IBT, Prague;
esearch projects AV0Z50520701, Grant Agency of the Czech
epublic [P303/13/02154S] and BIOCEV CZ.1.05/1.1.00/02.0109.
eferences
[1] Higuchi R, et al. Simultaneous ampliﬁcation and detection of speciﬁc DNA
sequences. Biotechnology (N Y) 1992;10(4):413–7.
[2] Kubista M,  et al. The real-time polymerase chain reaction. Mol  Aspects Med
2006;27(2–3):95–125.
[3] Wittwer CT, et al. Continuous ﬂuorescence monitoring of rapid cycle DNA
ampliﬁcation. Biotechniques 1997;22(1):130–1, 134–8.
[4] Hellemans J, et al. qBase relative quantiﬁcation framework and software
for management and automated analysis of real-time quantitative PCR data.
Genome Biol 2007;8(2):R19.[5] Pfafﬂ MW.  A new mathematical model for relative quantiﬁcation in real-time
RT-PCR. Nucleic Acids Res 2001;29(9):e45.
[6] Boeuf P, et al. CyProQuant-PCR: a real time RT-PCR technique for proﬁling
human cytokines, based on external RNA standards, readily automatable for
clinical use. BMC  Immunol 2005;6:5.
[
[nd Quantiﬁcation 3 (2015) 9–16
[7] Bustin SA. Absolute quantiﬁcation of mRNA using real-time reverse transcrip-
tion polymerase chain reaction assays. J Mol  Endocrinol 2000;25(2):169–93.
[8] Larionov A, Krause A, Miller W.  A standard curve based method for relative real
time PCR data processing. BMC  Bioinformatics 2005;6:62.
[9] Stolovitzky G, Cecchi G. Efﬁciency of DNA replication in the polymerase chain
reaction. Proc Natl Acad Sci U S A 1996;93(23):12947–52.
10] Alvarez MJ,  et al. Model based analysis of real-time PCR data from DNA  binding
dye protocols. BMC  Bioinformatics 2007;8:85.
11] Lalam N. Estimation of the reaction efﬁciency in polymerase chain reaction. J
Theor Biol 2006;242(4):947–53.
12] Roche. Overview of LightCycler quantiﬁcation methods; 2000.
13] AppliedBiosystems. Ampliﬁcation efﬁciency of TaqMan® gene expression
assays; 2004.
14] Goll R, et al. Evaluation of absolute quantitation by nonlinear regression in
probe-based real-time PCR. BMC  Bioinformatics 2006;7:107.
15] Tichopad A, et al. Standardized determination of real-time PCR efﬁciency from
a  single reaction set-up. Nucleic Acids Res 2003;31(20):e122.
16] Bustin SA, et al. The MIQE guidelines: minimum information for publication of
quantitative real-time PCR experiments. Clin Chem 2009;55(4):611–22.
17] Bar T, Kubista M,  Tichopad A. Validation of kinetics similarity in qPCR. Nucleic
Acids Res 2012;40(4):1395–406.
18] Sisti D, et al. Shape based kinetic outlier detection in real-time PCR. BMC  Bioin-
formatics 2010;11:186.
19] Tichopad A, et al. Quality control for quantitative PCR based on ampliﬁcation
compatibility test. Methods 2010;50(4):308–12.
20] Gevertz JL, Dunn SM,  Roth CM.  Mathematical model of real-time PCR kinetics.
Biotechnol Bioeng 2005;92(3):346–55.
21] Mackay IM. Real-time PCR in microbiology: from diagnosis to characterization.
Horizon Scientiﬁc Press; 2007. p. 454.
22] Raghavachari R, Tan W.  Genomics and proteomics technologies. San Jose, CA:
SPIE; 2001.
23] Nolan T, et al. SPUD: a quantitative PCR assay for the detection of inhibitors in
nucleic acid preparations. Anal Biochem 2006;351(2):308–10.
24] Svec D, et al. Direct cell lysis for single-cell gene expression proﬁling. Front
Oncol 2013;3:274.
25] Stahlberg A, et al. Quantitative real-time PCR method for detection
of  B-lymphocyte monoclonality by comparison of kappa and lambda
immunoglobulin light chain expression. Clin Chem 2003;49(1):51–9.
26] Pfafﬂ M.  In: Bustin SA, editor. Quantiﬁcation strategies in real-time PCR, A–Z of
quantitative PCR. La Jolla, CA, USA: International University Line (IUL); 2004. p.
87–112.
27] Good IJ. Some statistical applications of Poisson’s work. In: Statistical science.
Institute of Mathematical Statistics; 1986. p. 157–70.
28] Peccoud J, Jacob C. Theoretical uncertainty of measurements using quantitative
polymerase chain reaction. Biophys J 1996;71(1):101–8.
29] Bengtsson M,  et al. Quantiﬁcation of mRNA in single cells and modelling of
RT-qPCR induced noise. BMC  Mol  Biol 2008;9:63.
30] Murphy J, Bustin SA. Reliability of real-time reverse-transcription PCR in
clinical diagnostics: gold standard or substandard? Expert Rev Mol Diagn
2009;9(2):187–97.
31] Baker SC, et al. The External RNA Controls Consortium: a progress report. Nat
Methods 2005;2(10):731–4.
32] FDA. Guidance for industry pharmacogenomic data submissions. Food and Drug
Administration; 2005.
33] EPA. Quality assurance/quality control guidance for laboratories performing
PCR analyses on environmental samples. U.S. Environmental Protection Agency
(EPA), Ofﬁce of Ground Water and Drinking Water and the Ofﬁce of Research
and Development; 2004.
34] CLSI. Use of external RNA controls in gene expression assays. CLSI; 2006.
35] Lavagnini I, Magno F. A statistical overview on univariate calibration, inverse
regression, and detection limits: application to gas chromatography/mass spec-
trometry technique. Mass Spectrom Rev 2007;26(1):1–18.
36] Andrade JM, et al. Classical linear regression by the least squares method.
In:  Andrade-Garda JM,  editor. Basic chemometric techniques in atomic spec-
troscopy. 2nd ed. Royal Society of Chemistry; 2013. p. 52–66.
37] CLSI. CLSI document EP6-A: evaluation of the linearity of quantitative measure-
ment procedures; 2003.
38] CLSI. CLSI document EP5-A2: evaluation of precision performance of quantita-
tive measurement methods. 2nd ed; 2004.39] Cuthbert D. Calibration designs for machines with carry-over and drift. J Qual
Technol 1975;7(3):103–8.
40] Kubista M.  When to use interplate calibrator; 2010. Available from: http://
www.tataa.com/products-page/quality-assessment/tataa-interplate-
calibrator/
